The Cancer Immunology and Immunotherapy Centre (CIIC) is a collaborative grouping of academic and clinical research groups based at the University of Birmingham and the Queen Elizabeth Hospital Birmingham. They are collectively focused on developing internationally outstanding basic tumour immunology research and translating key discoveries into improvements in cancer treatment.
Also in 'Cancer Immunology and Immunotherapy Centre'
Latest videos
Cancer immunology research at the University of Birmingham
The future of cancer treatment
Latest News
Posted 19 November 2019
Professor Ben Willcox from the University of Birmingham's Institute of Immunology and Immunotherapy writes for the British Society of Immunology on the UK-wide Tumour Immunology Group.
Posted 19 November 2019
Researchers in the University of Birmingham's Institute of Immunology and Immunotherapy have discovered a new target recognised by local T-cells involved in immunosurveillance in the gut.
Posted 29 October 2019
Dr Leila Khoja joins Birmingham from AstraZeneca and Addenbrooke's Hospital, bringing with her an extensive experience in translating immunotherapies from bench to bedside.
View all news
TWITTER